Compound | Species | IC50 | References |
---|---|---|---|
µM | |||
Natural compounds | |||
Emodin | Human, rat | 3, 1 | Liu et al., 2010; Jelassi et al., 2013; Zhu et al., 2014 |
Berberine | Human | N.D. | Shemon et al., 2004 |
Sanginine | Human | N.D. | Shemon et al., 2004 |
Niphatoxin C | Human | >10 | Buchanan et al., 2007b |
Sytlissadine A | Human | 1 | Buchanan et al., 2007a |
Sytlissadine B | Human | 2 | Buchanan et al., 2007a |
17β-Estradiol | Human | 3 | Cario-Toumaniantz et al., 1998 |
Enzyme inhibitors | |||
KN-62 | Human, mouse | 0.1, 1 | Gargett and Wiley, 1997; Donnelly-Roberts et al., 2009 |
Chelerythrine | Human | 6 | Shemon et al., 2004 |
Ro 31-8220 | Human | N.D. | Shemon et al., 2007 |
Compound P | Human, dog | 5, N.D. | Shemon et al., 2008 |
SB-203580 | Human | 0.4–4 | Michel et al., 2006 |
SB-202190 | Human | 0.6–16 | Michel et al., 2006 |
CAY10593 | Human | 2 | Pupovac et al., 2013b |
CAY10594 | Human | >10 | Pupovac et al., 2013b |
Halopemide | Human | >10 | Pupovac et al., 2013b |
Therapeutic drugs | |||
Colchicine | Human, mouse, rat | N.D. | Marques-da-Silva et al., 2011 |
Prochlorperazine | Human | 1 | Hempel et al., 2013 |
Trifluoperazine | Human | 2 | Hempel et al., 2013 |
Triflupromoazine | Human | >50 | Hempel et al., 2013 |
Probenecid | Human | 200 | Bhaskaracharya et al., 2014 |
N.D., not determined.